Uptake of core outcome sets by clinical trialists in China: a protocol
Open Access
- 23 August 2023
- journal article
- research article
- Published by F1000 Research Ltd in F1000Research
- Vol. 12, 1030
Abstract
Background: The concept of core outcome sets (COS) has been introduced in China for about 10 years. In recent years, some Chinese researchers also committed to developing COS, though the majority of COS are ongoing. However, there were more than 500 published COS for research in the COMET database by 2020. Whether the disease category of ongoing and completed COS include the burden of disease in China is unclear. In addition, whether the published COS are used by clinical trialists is also unclear. In this research, we would like to investigate if COS are applicable to the burden of disease in China, and to ascertain whether completed COS are used by clinical trialists in China. Methods: The main burden of disease in China will be identified. Then we will search the COMET database to identify if there are ongoing or completed relevant COS research since 2012. Only COS for clinical trials or clinical research will be included. We will extract scopes of published eligible COS, including condition, population, interventions, and core outcomes. Then we will search the Chinese Clinical Trial Registry using disease names for each disease that has a published COS. We will assess the overlap in scope between clinical trials and COS. Then we will conduct an online survey and semi-structured interviews to identify the knowledge and perceptions of COS among primary investigators of included clinical trials. Discussion: This research will fill in gaps between COS and the burden of disease in China. Understanding clinical trialists’ knowledge and perceptions of COS may help dissemination and application of COS in the future. Trial registration: This research is registered in Core Outcome Measures in Effectiveness: https://www.comet-initiative.org/Studies/Details/2563.Keywords
Funding Information
- National Natural Science Foundation of China (81904051)
- University of Liverpool
- Qihuang Scholar of National Administration of Traditional Chinese Medicine (RS086)
- MRC Trials Methodology Research Partnership (MR/S014357/1)
- Young Elite Scientists Sponsorship Program by CACM (CACM-2019-NRC2-A03)
- National Institute for Health Research (NIHR) Senior Investigator award (NF-SI_0513-10025)
This publication has 6 references indexed in Scilit:
- Review finds core outcome set uptake in new studies and systematic reviews needs improvementJournal of Clinical Epidemiology, 2022
- In-depth qualitative interviews identified barriers and facilitators that influenced chief investigators’ use of core outcome sets in randomised controlled trialsJournal of Clinical Epidemiology, 2022
- More than half of systematic reviews have relevant core outcome setsJournal of Clinical Epidemiology, 2021
- Choosing important health outcomes for comparative effectiveness research: 6th annual update to a systematic review of core outcome sets for researchPLOS ONE, 2021
- Core Outcome Set-STAndards for Development: The COS-STAD recommendationsPLOS Medicine, 2017
- Clinical Research of Traditional Chinese Medicine Needs to Develop Its Own System of Core Outcome SetsEvidence-Based Complementary and Alternative Medicine, 2013